{
    "title": "Growth hormone increased height of children more if higher levels of vitamin D",
    "slug": "growth-hormone-increased-height-of-children-more-if-higher-levels-of-vitamin-d",
    "aliases": [
        "/Growth+hormone+increased+height+of+children+more+if+higher+levels+of+vitamin+D+\u2013+Aug+2015",
        "/6783"
    ],
    "tiki_page_id": 6783,
    "date": "2015-08-09",
    "categories": [
        "Infant-Child"
    ],
    "tags": [
        "Infant-Child",
        "autoimmune",
        "blood levels",
        "bone",
        "bone cancer",
        "cancer",
        "cancer in VDR",
        "child",
        "childhood cancer",
        "dosage",
        "genetics",
        "high dose",
        "intervention",
        "pain",
        "pediatric autoimmune",
        "rheumatoid arthritis",
        "rickets",
        "therapeutic intervention",
        "vitamin d",
        "vitamin d blood test",
        "vitamin d receptor",
        "vitamin k"
    ]
}


#### Seasonal variations in vitamin D in relation to growth in short prepubertal children before and during first year growth hormone treatment

Journal of Endocrinological Investigation, August 2015

B. Andersson, D. Swolin-Eide, B. Kriström, L. Gelander, P. Magnusson, K. Albertsson-Wikland

<div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:750px">

* [Search VitaminDWiki for “GROWTH HORMONE”](https://www.VitaminDWiki.com/Search+Results?hl=en&oe=UTF-8&ie=UTF-8&btnG=Google+Search&googles.x=0&googles.y=0&q=polar&domains=VitaminDWiki.com&sitesearch=VitaminDWiki.com) 176 items as of March 2018

* [Growth Hormone treatment raised vitamin D levels by 16 ng – 2018](/posts/growth-hormone-treatment-raised-vitamin-d-levels-by-16-ng-2018)

* [Growth Hormone problem (Acromegaly) more likely if vitamin D gene problems](/posts/growth-hormone-problem-acromegaly-more-likely-if-vitamin-d-gene-problems)

* [Increased growth factors with vitamin D and Vitamin K2 – May 2012](/posts/increased-growth-factors-with-vitamin-d-and-vitamin-k2)

* [Human grown hormone (IGF1) in seniors greatly increased with 7,000 IU of vitamin D – Sept 2013](/posts/human-grown-hormone-igf1-in-seniors-greatly-increased-with-7000-iu-of-vitamin-d)

* [Growth Hormone Deficiency treated by treating Vitamin D Deficiency – March 2019](/posts/growth-hormone-deficiency-treated-by-treating-vitamin-d-deficiency)

* [Growth Hormone treatment raised vitamin D levels – May 2014](/posts/growth-hormone-treatment-raised-vitamin-d-levels) summary by VitaminDWiki

 **| | | | |
| --- | --- | --- | --- |
| Season | Before GH | After GH | % increase |
| Summer | 31 ng | 39 ng | <span style="color:#F00;">30 %</span> |
| Winter | 17 ng | 30 ng | <span style="color:#F00;">76%</span> |** 

</div>

Purpose

This study investigated the relationship between seasonal variations in 25-hydroxyvitamin D (25(OH)D) levels and growth in prepubertal children during both the pretreatment year and the first year of GH treatment.

Methods

The study included 249 short prepubertal children with a broad range of GH secretion, GHmax during a 24 h profile median 23; range 1–127 mU/L, 191 boys (mean age ± SD, 8.6 ± 2.6 years), 58 girls (7.5 ± 1.9 years) receiving GH treatment (mean 43 µg/kg/day; range 17–99 µg/kg/day). Serum 25(OH)D was measured using an automated IDS-iSYS immunoassay.

Results

25(OH)D levels showed seasonal variation, and decreased significantly during GH treatment. 25(OH)D levels at start and first year reduction in 25(OH)D, correlated (−) with the first year growth response during treatment. The degree of GH secretion capacity within our study population of mainly non-GH deficient children and 25(OH)D sufficient (67 ± 29 nmol/L) had no influence on 25(OH)D levels. Growth during GH treatment were independent of seasonal variations in 25(OH)D.  **Multiple regression analysis showed that 25(OH)D levels at treatment start, together with auxological data and IGF-binding protein-3SDS, explained 61 % of the variation in first year gain in height SDS.** 

Conclusion

25(OH)D levels were associated with first year growth response to GH and may be a useful contribution to future growth prediction models.

### References

* 1.Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281. doi:10.​1056/​NEJMra070553 PubMedView Article

* 2.Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96(1):53–58. doi:10.​1210/​jc.​2010-2704 PubMed CentralPubMedView Article

* 3.Holick MF (2008) Vitamin D: a D-Lightful health perspective. Nutr Rev 66(10 Suppl 2):S182–S194. doi:10.​1111/​j.​1753-4887.​2008.​00104.​x PubMedView Article

* 4.Stamp TC, Round JM (1974) Seasonal changes in human plasma levels of 25-hydroxyvitamin D. Nature 247(5442):563–565PubMedView Article

* 5.Kuhn T, Kaaks R, Teucher B, Hirche F, Dierkes J, Weikert C, Katzke V, Boeing H, Stangl GI, Buijsse B (2014) Dietary, lifestyle, and genetic determinants of vitamin D status: a cross-sectional analysis from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study. Eur J Nutr 53(3):731–741. doi:10.​1007/​s00394-013-0577-8 PubMedView Article

* 6.Toss G, Magnusson P (2012) Vitamin D status: sunshine is nice but other factors prevail. Eur J Nutr 51(2):255–256View Article

* 7.Klaus G, Merke J, Eing H, Hugel U, Milde P, Reichel H, Ritz E, Mehls O (1991) 1,25(OH)2D3 receptor regulation and 1,25(OH)2D3 effects in primary cultures of growth cartilage cells of the rat. Calcif Tissue Int 49(5):340–348PubMedView Article

* 8.Schwartz Z, Schlader DL, Ramirez V, Kennedy MB, Boyan BD (1989) Effects of vitamin D metabolites on collagen production and cell proliferation of growth zone and resting zone cartilage cells in vitro. J Bone Miner Res 4(2):199–207. doi:10.​1002/​jbmr.​5650040211 PubMedView Article

* 9.Schwartz Z, Brooks B, Swain L, Del Toro F, Norman A, Boyan B (1992) Production of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by growth zone and resting zone chondrocytes is dependent on cell maturation and is regulated by hormones and growth factors. Endocrinology 130(5):2495–2504PubMed

* 10.Gerstenfeld LC, Kelly CM, Von Deck M, Lian JB (1990) Effect of 1,25-dihydroxyvitamin D3 on induction of chondrocyte maturation in culture: extracellular matrix gene expression and morphology. Endocrinology 126(3):1599–1609PubMedView Article

* 11.Yamamoto Y, Yoshizawa T, Fukuda T, Shirode-Fukuda Y, Yu T, Sekine K, Sato T, Kawano H, Aihara K, Nakamichi Y, Watanabe T, Shindo M, Inoue K, Inoue E, Tsuji N, Hoshino M, Karsenty G, Metzger D, Chambon P, Kato S, Imai Y (2013) Vitamin d receptor in osteoblasts is a negative regulator of bone mass control. Endocrinology 154(3):1008–1020. doi:10.​1210/​en.​2012-1542 PubMedView Article

* 12.Nilsson O, Marino R, De Luca F, Phillip M, Baron J (2005) Endocrine regulation of the growth plate. Horm Res 64(4):157–165PubMedView Article

* 13.Albertsson-Wikland K, Alm F, Aronsson S, Gustafsson J, Hagenas L, Hager A, Ivarsson S, Kristrom B, Marcus C, Moell C, Nilsson KO, Ritzen M, Tuvemo T, Westgren U, Westphal O, Aman J (1999) Effect of growth hormone (GH) during puberty in GH-deficient children: preliminary results from an ongoing randomized trial with different dose regimens. Acta Paediatr Suppl 88(428):80–84PubMedView Article

* 14.Albertsson-Wikland K, Kristrom B, Lundberg E, Aronson AS, Gustafsson J, Hagenas L, Ivarsson SA, Jonsson B, Ritzen M, Tuvemo T, Westgren U, Westphal O, Aman J (2014) Growth hormone dose-dependent pubertal growth: a randomized trial in short children with low growth hormone secretion. Horm Res Paediatr 82(3):158–170. doi:10.​1159/​000363106 PubMedView Article

* 15.Albertsson-Wikland K, Aronson AS, Gustafsson J, Hagenas L, Ivarsson SA, Jonsson B, Kristrom B, Marcus C, Nilsson KO, Ritzen EM, Tuvemo T, Westphal O, Aman J (2008) Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency. J Clin Endocrinol Metab 93(11):4342–4350PubMedView Article

* 16.Gelander L, Karlberg J, Albertsson-Wikland K (1994) Seasonality in lower leg length velocity in prepubertal children. Acta Paediatr 83(12):1249–1254PubMedView Article

* 17.Land C, Blum WF, Stabrey A, Schoenau E (2005) Seasonality of growth response to GH therapy in prepubertal children with idiopathic growth hormone deficiency. Eur J Endocrinol 152(5):727–733. doi:10.​1530/​eje.​1.​01899 PubMedView Article

* 18.Shulman DI, Frane J, Lippe B (2013) Is there “seasonal” variation in height velocity in children treated with growth hormone? Data from the national cooperative growth study. Int J Pediatr Endocrinol 1:2. doi:10.​1186/​1687-9856-2013-2 View Article

* 19.Kristrom B, Aronson AS, Dahlgren J, Gustafsson J, Halldin M, Ivarsson SA, Nilsson NO, Svensson J, Tuvemo T, Albertsson-Wikland K (2009) Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature. J Clin Endocrinol Metab 94(2):483–490PubMedView Article

* 20.Albertsson-Wikland K, Kristrom B, Rosberg S, Svensson B, Nierop AF (2000) Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities. Pediatr Res 48(4):475–484View Article

* 21.Bodnar LM, Catov JM, Wisner KL, Klebanoff MA (2009) Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera frozen for over 40 years. Br J Nutr 101(2):278–284. doi:10.​1017/​S000711450898146​0 PubMed CentralPubMedView Article

* 22.Karlberg J (1989) On the construction of the infancy-childhood-puberty growth standard. Acta Paediatr Scand Suppl 356:26–37PubMedView Article

* 23.Albertsson-Wikland K, Luo ZC, Niklasson A, Karlberg J (2002) Swedish population-based longitudinal reference values from birth to 18 years of age for height, weight and head circumference. Acta Paediatr 91(7):739–754View Article

* 24.Niklasson A, Albertsson-Wikland K (2008) Continuous growth reference from 24th week of gestation to 24 months by gender. BMC Pediatr 8:8. doi:10.​1186/​1471-2431-8-8 PubMed CentralPubMedView Article

* 25.Karlberg J, Luo ZC, Albertsson-Wikland K (2001) Body mass index reference values (mean and SD) for Swedish children. Acta Paediatr 90(12):1427–1434PubMedView Article

* 26.Luo ZC, Albertsson-Wikland K, Karlberg J (1998) Target height as predicted by parental heights in a population-based study. Pediatr Res 44(4):563–571PubMedView Article

* 27.Penny R, Blizzard RM, Davis WT (1969) Sequential arginine and insulin tolerance tests on the same day. J Clin Endocrinol Metab 29(11):1499–1501. doi:10.​1210/​jcem-29-11-1499 PubMedView Article

* 28.Albertsson-Wikland K, Rosberg S (1988) Analyses of 24 hour growth hormone profiles in children: relation to growth. J Clin Endocrinol Metab 67(3):493–500PubMedView Article

* 29.Jansson C, Boguszewski C, Rosberg S, Carlsson L, Albertsson-Wikland K (1997) Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein. Clin Chem 43(6 Pt 1):950–956PubMed

* 30.Le Goff C, Peeters S, Crine Y, Lukas P, Souberbielle JC, Cavalier E (2012) Evaluation of the cross-reactivity of 25-hydroxyvitamin D2 on seven commercial immunoassays on native samples. Clin Chem Lab Med 50(11):2031–2032. doi:10.​1515/​cclm-2012-0164 PubMed

* 31.Löfqvist C, Andersson E, Gelander L, Rosberg S, Blum WF, Albertsson-Wikland K (2001) Reference values for IGF-I throughout childhood and adolescence: a model that accounts simultaneously for the effect of gender, age, and puberty. J Clin Endocrinol Metab 86(12):5870–5876PubMedView Article

* 32.Lofqvist C, Andersson E, Gelander L, Rosberg S, Hulthen L, Blum WF, Wikland KA (2005) Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence. J Clin Endocrinol Metab 90(3):1420–1427PubMedView Article

* 33.Wei S, Tanaka H, Kubo T, Ono T, Kanzaki S, Seino Y (1997) Growth hormone increases serum 1,25-dihydroxyvitamin D levels and decreases 24,25-dihydroxyvitamin D levels in children with growth hormone deficiency. Eur J Endocrinol 136(1):45–51PubMedView Article

* 34.Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, Di Nero G (1993) Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr 122(1):37–45PubMedView Article

* 35.Ciresi A, Ciccio F, Giordano C (2014) High prevalence of hypovitaminosis D in Sicilian children affected by growth hormone deficiency and its improvement after 12 months of replacement treatment. J Endocrinol Invest 37(7):631–638. doi:10.​1007/​s40618-014-0084-7 PubMedView Article

* 36.Hypponen E, Fararouei M, Sovio U, Hartikainen AL, Pouta A, Robertson C, Whittaker JC, Jarvelin MR (2011) High-dose vitamin D supplements are not associated with linear growth in a large Finnish cohort. J Nutr 141(5):843–848. doi:10.​3945/​jn.​110.​133009 PubMedView Article

* 37.Hochberg Z (2003) Vitamin D and Rickets. S Karger AG, BaselView Article

* 38.Bellone S, Esposito S, Giglione E, Genoni G, Fiorito C, Petri A, Bona G, Prodam F (2014) Vitamin D levels in a paediatric population of normal weight and obese subjects. J Endocrinol Invest 37(9):805–809. doi:10.​1007/​s40618-014-0108-3 PubMedView Article

* 39.Holick MF, Schnoes HK, DeLuca HF, Gray RW, Boyle IT, Suda T (1972) Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D made in the kidney. Biochemistry 11(23):4251–4255PubMedView Article

* 40.Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930. doi:10.​1210/​jc.​2011-0385 PubMedView Article

* 41.Bailey D, Colantonio D, Kyriakopoulou L, Cohen AH, Chan MK, Armbruster D, Adeli K (2013) Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort. Clin Chem 59(9):1393–1405. doi:10.​1373/​clinchem.​2013.​204222 PubMedView Article

* 42.Franchi B, Piazza M, Sandri M, Tenero L, Comberiati P, Boner AL, Capristo C (2014) 25-hydroxyvitamin D serum level in children of different ethnicity living in Italy. Eur J Pediatr. doi:10.​1007/​s00431-014-2451-y

* 43.Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA, Powe NR, Thadhani R (2013) Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 369(21):1991–2000. doi:10.​1056/​NEJMoa1306357 PubMed CentralPubMedView Article

 **[Publisher wants $40 for the PDF](http://link.springer.com/article/10.1007/s40618-015-0360-1)**